Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer
Authors:
- Montserrat Sanchez-CespedesMSMontserrat Sanchez-Cespedes
- Andre L ReedARAndre L Reed
- Martin ButaMBMartin Buta
- Li WuLWLi Wu
- William H WestraWWWilliam H Westra
- James G HermanJHJames G Herman
- Stephen C YangSYStephen C Yang
- Jin JenJJJin Jen
- David SidranskyDSDavid Sidransky
- 21 October 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (43) , 5843-5849
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 14 references indexed in Scilit:
- The INK4a/ARF tumor suppressor: one gene—two products—two pathwaysTrends in Biochemical Sciences, 1998
- Atlas Florae EuropaeaeNordic Journal of Botany, 1996
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- Cancer genetics: Two tracks but one race?Current Biology, 1996
- p53: puzzle and paradigm.Genes & Development, 1996
- Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursNature Genetics, 1995
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995
- Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p LossScience, 1994
- Oncogenes in human lung cancer1993
- Identification of p53 Gene Mutations in Bladder Cancers and Urine SamplesScience, 1991